Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T09:10:18.859Z Has data issue: false hasContentIssue false
  • English
  • Français

Editorial

Published online by Cambridge University Press:  20 January 2017

Alberto Alemanno
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
European Journal of Risk Regulation , Volume 5 , Issue 3 , September 2014 , pp. 283 - 285
Copyright
Copyright © Cambridge University Press 2014

References

1 Letter signed by Greenpeace, Heal, Test Biotech, RES, Corporate Observatory Europe, Pesticide Action Network, EarthOpenSource, Sciences Citoyennes and send to President–elect Juncker on July 22, 2014, available at <http://corporateeurope.org/sites/default/files/attachments/ngo_letter_on_chief_scientific_adviser_-_final.pdf.> The publication of this letter was in turn prompted by BUSINESSEUROPE President’sletter (Emma Marcegaglia) addressed to José Manuel Barroso, Science, governance and a stronger European Union: a strengthened role for the Chief Scientific Advisor, available at <http://www.businesseurope.eu/content/default.asp?PageID=568&DocID=33005>

2 Case C-270/12, United Kingdom v. Council and Parliament, annotated by Simone Gabbi in EJRR 2/14 (pp. 259–266).